Alberta Reappraising AIDS Society |
||||||
David Crowe, President Phone: +1-403-289-6609 Fax: +1-403-289-6658 Email: David.Crowe@aras.ab.ca Kathleen Newell, Treasurer |
Box 61037, Kensington Postal Outlet
Calgary, Alberta T2N 4S6 Canada |
|||||
Rethinkers | Quotes | AZT | HAART | HIV Tests | Transmission | Library |
The future is wirtten in emerging history. As it is emerging and slowly creeping upon us, we find medical associations banning doctors from prescribing natural antioxidants and micronutrients as supplements to restore health in favor of pharmaceutically prescribed drugs that are not part of the normal and healthy biochemistry of cells but rather can be detrimental to that very life-giving biochemistry and biochemical pathways and we find toxic poisons like AZT that could not be approved for chemotherapy due to its extreme toxicity being presented as a retoviral in conditions like AIDS that is associated with malnutrition and attendant oxidative stress that impairs health rather than a virus proven through the gold standard. Coversely, within this scenario, one should expect toxic chemo being repositioned in the market as a retroviral. That naturally broadens the market and fattens the bottom line.
And it has already happened! Since the mortality from H5N1 infection is high, and there is concern that the virus could cause a pandemic, novel treatments for human beings are warranted, Henter said in his hypothesis published online by The Lancet medical journal. There are scientists who believe that a chemotherapy treatment given to patients with an immune system disorder may work for human avian influenza The chemotherapy drug etoposide, which helps kill excess immune cells is the basis for the treatment for an illness known as haemophagocytic lympho-histiocytosis (HLH) because there are clinical similarities. Many disease conditions today are not like scurvy, typhoid, beri-beri, TB or malaria. Many conditions are caused by free radical initiated reactions in the body by the prolonged use of recreational drugs, toxic drugs, toxic ingredients in cosmetic products or pesticides or fuels and medicinal drugs. It is OK to treat conditions like immune disorders that may be caused by free radical damage to biochemical pathways or signalling mechanisms with toxic drugs that (generate free radicals in the body) and could cause similar damage or collateral damage in other systems or cause endothelial dysfunction and the excess NO could interfere with signalling biomolecules.
Medical science, as it presents itself today, is largely a treatment science wherein disease conditions are to be treated with drugs having abandoned health science which is about restoring health through biomolecules that promote and restore cellular function. This chronic deviation is slowly and progressively repositioning toxic drugs and chemicals as clinically useful and later on as harmless or even beneficial for people who have not yet developed any symptoms. As a strategy, toxic drugs appear to be moving in that cycle and AZT is a good example that has dogmatic support.
Mothers who received long AZT treatment had a higher rate of stillbirth (8% vs. 4%), severe anemia (7% vs 4%), infection or other HIV events (20% vs 17%), events related to pregnancy or delivery (24% vs 17%) than mothers who received the short course, although fewer died (3% vs 8%) (Lallemant M et al. A trial of shortened zidovudine regimens to prevent mother-to- child transmission of human immunodeficiency virus type 1. NEJM. 2000 Oct 5;343(14):982-91). Infants with early positive HIV-1 cultures demonstrated a notable decrement in neurodevelopmental functioning within the first 30 months of life. They achieved motor developmental scores that were increasingly and significantly discrepant [worse] both from the average and from scores achieved by late HIV-1-positive children over the course of the study period (Smith R et al. Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. Pediatr Infect Dis J. 2000;19:862-71). The UKs Committee on Safety of Medicines has issued a warning to doctors about the risk of mitochondrial dysfunction in infants (Perinatal AZT: New warning on potential risk to infants. www.aidsmap.com. 1999 Jul 21, http://www.aidsmap.com/namsearch.htm/news/07jul99/story6.htm). The data show that AZT crosses the human placenta and becomes rapidly incorporated into DNA of placental tissue in a dose-dependent fashion, suggesting that even short exposures to this drug might induce fetal genotoxicity and might also inhibit maternal-fetal viral transmission (Olivero OA et al. 3-azido-3-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT. Mutat Res Fundam Mol Mech Mutagen. 1999 Jul 16;428(1-2):41-7). Yet it is precribed as a medicine to pregnant mothers and infants!
AZT can be severely toxic, and there is compelling evidence that the drug probably doesnt help infected people live longer unless they already have full-blown AIDS AZT clearly isnt a very effective anti-AIDS drug (Cohen J. Fulfilling Kochs Postulates. Science. 1994 Dec 9;266:1647). Yet, there is a dogmatic medical fraternity that insists on AZT as a necessary medicine!
There are many studies that show the extreme toxicity of AZT on blood and bone marrow, in promoting cancers, liver dysfunction and on mitochondria leading to fatigue, muscle wasting and suppression of the immune system. All of these are characteristic of a poison that generates a large number of free radicals in the body. It causes anaemia in all mammals. Its medium term use could certainly suppress and weaken the immune system sufficiently to open the body to opportunistic infections - just like in AIDS! Yet it is a medication!.
The following is a list of some of the serious adverse reactions to AZT that have been observed in infants, children, and adults who took AZT for certain periods of time. It tells the story of the suffering of patients treated with AZT. These reactions include: Neutropenia, granulocytopenia, anemia, thrombocytopenia, myopathy and myositis, hepatomegaly with steatosis, hepatitis, pancreatitis, lactic acidosis, sensitization reactions, hyperbilirubinemia, vasculitis, abdominal pain, back pain, body odor, chest pain, chills, edema of the lip, fever, flu syndrome, hyperalgesia, syncope, vasodilation, bleeding gums, constipation, diarrhea, dysphagia, edema of the tongue, eructation, flatulence, mouth ulcer, rectal hemorrhage, lymphadenopathy, arthralgia, muscle spasm, tremor, twitch, anxiety, confusion, depression, dizziness, emotional lability, loss of mental acuity, nervousness, paresthesia, somnolence, vertigo, cough, dyspnea, epistaxis, hoarseness, pharyngitis, rhinitis, sinusitis, acne, changes in skin and nail pigmentation, pruritus, rash, sweat, urticaria, amblyopia, hearing loss, photophobia, taste perversion, dysuria, polyuria, urinary frequency, and urinary hesitancy (Mohammed Ali Al-Bayati Ph.D. www.shirleys-wellness-cafe.com/aids_healing.htm). Does it not look like a medicine that causes a wide range of illnesses?
The large Anglo-French Concorde randomized trial of zidovudine in asymptomatic HIV-infected individuals shows that there is no significant clinical benefit in terms of survival or disease progression to AIDS or AIDS-related complex (ARC) in those who started zidovudine immediately rather than those who waited for the onset of symptomatic disease. The 1749 participants were followed up for an average of 3 years (Press Release: Results from Concorde Trial of AZT vs. Placebo. Medical Research Council. 1993 Apr 2; cf David Crowe, June 2001)). Why would a toxic drug that has no significant clinical benefit and that causes so many health complications be used as a medicine?
AZT does not prevent the spread of AIDS. AZT does not improve quality of life of AIDS patients. AZT does increase the average life span of AIDS patients. In facts, science shows it to be just the opposite. AZT debilitates the body. AZT weakens or suppresses the immune system and that precipitates more health problems makes the chances of recovery more remote. It does not extend lives, only shorten them. Tragically, AZT can cause AIDS. Yet, there is a medical fraternity who insist that AZT is a medicine!
THE AZT LABEL - This is what the patient never sees, an actual copy of an AZT label. This label has appeared on bottles containing as little as 25 milligrams, a small fraction (1/20 to 1/50) of some patients daily prescribed dose. WARNING: RETROVIR (ZIDOVUDINE) [AZT] MAY BE ASSOCIATED WITH HEMATOLOGIC TOXICITY INCLUDING GRANULOCYTOPENIA AND SEVERE ANEMIA PARTICULARLY IN PATIENTS WITH ADVANCED HIV DISEASE ( SEE WARNINGS). PROLONGED USE OF RETROVIR [AZT] HAS BEEN ASSOCIATED WITH SYMPTOMATIC MYOPATHY SIMILAR TO THAT PRODUCED BY HUMAN IMMUNODEFICIENCY VIRUS. RARE OCCURRENCES OF LACTIC ACIDOSIS IN THE ABSENCE OF HYPOXEMIA, AND SEVERE HEPATOMEGALY WITH STEATOSIS HAVE BEEN REPORTED WITH THE USE OF ANTIRETROVIRAL NUCLEOSIDE ANALOGUES, INCLUDING RETROVIR AND ZALCITABINE, AND ARE POTENTIALLY FATAL ( SEE WARNINGS). - from Glaxo Welcome AZT product information. (See The AZT Label). If it now strikes you that here is a prescription drug that causes AIDS...well you cant be wrong, especially in consideration of the studies on AZT. It is precription AIDS or as Peter Duesberg calls it AZT AIDS. AZT therapy was officially indicated only for AIDS or ARC patients who either had a history of cytologically confirmed Pneumocystis carinii pneumonia (PCP) or an absolute CD4 (T4 helper/inducer) lymphocyte count of less than 200/cubic mm in the peripheral blood before therapy is begun. (Physicians Desk Reference) This changed dramatically when a series of press releases were issued by the National Institute of Allergy and Infectious Diseases (NIAID) and other branches of the Public Health Service (PHS), claiming that AZT was beneficial for HIV-infected persons with mild symptoms of immune system damage and also for HIV- infected persons who have not yet developed symptoms (AZT and Cancer, New York Native, 1987 October 19th, John Lauritsen: see Alberta Reappraising AIDS).
While retorivirals are being cross sold and recommended for use in chemotherapy and chemo drugs being recommended as retrovirals, the National Instutute of Allergy and Infectious Diseases (NIAID) and branches of the PHS have taken the dramatic step to promote AZT as beneficial for HIV-infected persons who have not yet developed symptoms. From here, it is not a quantum leap for scientists at such institutions to issue press releases to also say that it is beneficial for people suspected to have cancers but have not yet got their test results to take chemo supplements! So if these trends in medical science continue, the day is nigh when it shall be said, MOM, can I have my chemo supplement please. After all, there are so many products with glycols and parabens.